保留瓣膜的主动脉根部置换与复合带瓣管道根部置换的比较:来自2个主动脉中心的1500余例患者分析
本研究纳入2004至2021年间2个主动脉中心共1507例三叶式或二叶式主动脉瓣患者,比较保留瓣膜的主动脉根部置换(700例)、生物瓣复合带瓣管道根部置换(703例)与机械瓣复合带瓣管道根部置换(104例)的远期结局。多因素分析显示生物瓣复合带瓣管道(HR 1.91,P=0.001)与机械瓣复合带瓣管道(HR 2.62,P=0.005)的12年死亡风险均高于保留瓣膜的主动脉根部置换;倾向性评分匹配后保留瓣膜的主动脉根部置换12年生存率优于生物瓣复合带瓣管道(87.9% vs 78.8%,P=0.033)。三组再干预累积发生率分别为7%、17%和2%(P=0.420),4年 landmark 分析显示生物瓣复合带瓣管道远期再干预发生率高于保留瓣膜的主动脉根部置换(P=0.008)。
要点
- 保留瓣膜的主动脉根部置换的12年生存率优于生物瓣复合带瓣管道(87.9% vs 78.8%,P=0.033)。
- 生物瓣与机械瓣复合带瓣管道的12年死亡风险均高于保留瓣膜的主动脉根部置换(HR 1.91与HR 2.62)。
- 三组再干预累积发生率分别为7%、17%和2%,调整后再干预风险无显著差异(P=0.420)。
核心结论
- 保留瓣膜的主动脉根部置换、机械瓣复合带瓣管道和生物瓣复合带瓣管道均显示良好的12年生存率,其中保留瓣膜的主动脉根部置换与更好的生存相关。
- 三组再干预发生率均较低,保留瓣膜的主动脉根部置换相比生物瓣复合带瓣管道术后远期再干预需求减少。
研究设计与样本
- 多中心队列研究,纳入2004至2021年间2个主动脉中心共1507例患者,排除夹层、心内膜炎、狭窄或既往主动脉瓣手术者。
- 患者接受保留瓣膜的主动脉根部置换(n=700)、生物瓣复合带瓣管道(n=703)或机械瓣复合带瓣管道(n=104)。
- 采用多因素Cox回归比较调整后12年生存率,Fine和Gray竞争风险回归比较再干预风险与累积发生率,并行倾向性评分匹配及术后4年landmark分析。
主要发现
- 多因素分析显示生物瓣复合带瓣管道(HR 1.91,P=0.001)与机械瓣复合带瓣管道(HR 2.62,P=0.005)的12年死亡风险均高于保留瓣膜的主动脉根部置换。
- 倾向性评分匹配后保留瓣膜的主动脉根部置换12年生存率优于生物瓣复合带瓣管道(87.9% vs 78.8%,P=0.033)。
- 调整后12年再干预风险在生物瓣复合带瓣管道(亚分布HR 1.49,P=0.170)和机械瓣复合带瓣管道(亚分布HR 0.28,P=0.110)与保留瓣膜的主动脉根部置换之间相似。
- 再干预累积发生率在保留瓣膜的主动脉根部置换为7%、生物瓣复合带瓣管道为17%、机械瓣复合带瓣管道为2%(P=0.420)。
- 术后4年landmark分析显示生物瓣复合带瓣管道远期再干预发生率高于保留瓣膜的主动脉根部置换(P=0.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The long-term outcomes comparing valve-sparing root replacement, composite valve graft with bioprosthesis, and mechanical prosthesis have yet to be explored. We investigated the long-term survival and reintervention rates after 1 of 3 major aortic root replacements in patients with tricuspid aortic valves and patients with bicuspid aortic valves. METHODS: A total of 1507 patients underwent valve-sparing root replacement (n = 700), composite valve graft with bioprosthesis (n = 703), or composite valve graft with mechanical prosthesis (n = 104) between 2004 and 2021 in 2 aortic centers, excluding those with dissection, endocarditis, stenosis, or prior aortic valve surgery. End points included mortality over time and cumulative incidence of aortic valve/proximal aorta reintervention. Multivariable Cox regression compared adjusted 12-year survival. Fine and Gray competing risk regression compared the risk and cumulative incidence of reintervention. Propensity score-matched subgroup analysis balanced the 2 major groups (composite valve graft with bioprosthesis and valve-sparing root replacement), and landmark analysis isolated outcomes beginning 4 years postoperatively. RESULTS: On multivariable analysis, both composite valve graft with bioprosthesis (hazard ratio, 1.91, P = .001) and composite valve graft with mechanical prosthesis (hazard ratio, 2.62, P = .005) showed increased 12-year mortality risk versus valve-sparing root replacement. After propensity score matching, valve-sparing root replacement displayed improved 12-year survival versus composite valve graft with bioprosthesis (87.9% vs 78.8%, P = .033). Adjusted 12-year reintervention risk in patients receiving composite valve graft with bioprosthesis or composite valve graft with mechanical prosthesis versus valve-sparing root replacement was similar (composite valve graft with bioprosthesis subdistribution hazard ratio, 1.49, P = .170) (composite valve graft with mechanical prosthesis subdistribution hazard ratio, 0.28, P = .110), with a cumulative incidence of 7% in valve-sparing root replacement, 17% in composite valve graft with bioprosthesis, and 2% in composite valve graft with mechanical prosthesis (P = .420). Landmark analysis at 4 years showed an increased incidence of late reintervention in composite valve graft with bioprosthesis versus valve-sparing root replacement (P = .008). CONCLUSIONS: Valve-sparing root replacement, composite valve graft with mechanical prosthesis, and composite valve graft with bioprosthesis demonstrated excellent 12-year survival, with valve-sparing root replacement associated with better survival. All 3 groups have low incidence of reintervention, with valve-sparing root replacement showing decreased late postoperative need for reintervention compared with composite valve graft with bioprosthesis.
引用
- Levine D, Patel P, Wang C, et al. Valve-sparing root replacement versus composite valve graft root replacement: Analysis of more than 1500 patients from 2 aortic centers. J Thorac Cardiovasc Surg. 2023. PMID: 37245627. doi:10.1016/j.jtcvs.2023.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。